Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sirona-02 is an ingestible, hydrogel-based medical device or drug-device combination developed by Oxford Medical Products (OMP) specifically for weight maintenance. Administered as an oral capsule, the device expands upon reaching the stomach to occupy significant volume, thereby inducing a feeling of satiety through the mechanical stimulation of gastric stretch receptors. This physical mechanism is designed to help patients maintain weight loss achieved through previous interventions. The hydrogel is engineered to remain in the stomach for a controlled duration before safely degrading and passing through the gastrointestinal tract. Sirona-02 represents a specialized iteration of OMP's Sirona platform, distinct from Sirona-01 which is targeted at active weight loss in obesity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Sirona-02.